Skip to main content

This site provides INTERCEPT product information for International audiences Select your region

  • English
  • Deutsch
INTERCEPT Blood System™
  • About
  • Insights
  • Cerus Campus
  • COVID-19 News
  • Resources
  • Contact
  • Ask an expert
  • Blood center
  • Healthcare professional
  • General Blood Safety
menu
Home › Blood center › INTERCEPT › Platelets › What makes it unique?

What makes it unique?

The INTERCEP™ Blood System for platelets, the first pathogen inactivation technology made available to blood centres across the globe, offers many unique benefits. 

  • Level of Inactivation

    read more
  • Spectrum of Inactivation

    read more
  • Clinical Trials and Haemovigilance Programmes

    read more
  • Market Approval

    read more
  • Multiple Platelet Units At Once

    read more
  • Number of Transfusions

    read more
  • Unmatched Throughput

    read more
  • EU Medical Devices Standards

    read more
  • Unique Mode of Action

    read more

Newsletter

Want to stay updated on the latest pathogen inactivation news?
You can receive our highlights by subscribing to our newsletter.

Subscribe to our newsletter

Ask an Expert

Do you have questions about the INTERCEPT™ Blood System, blood safety or blood transfusions? The INTERCEPT team has plenty of knowledge and expertise.

Ask an Expert

  • Legal Info
  • Privacy Policy
  • Cookies

The information on this site is not country-specific, and may contain information that is outside the approved indications for the country in which you are located.
Use of INTERCEPT Plasma or Platelets is contraindicated in patients with a history or allergic response to amotosalen or psoralens. Consult instructions for use for indications, contraindications, warnings, and precautions. 

Cerus, INTERCEPT and the Cerus logo are trademarks of Cerus Corporation.

© 2025 Cerus Corporation. All Rights Reserved. MKT-EN 00157 v43.0